✦ LIBER ✦

441 Inhibitory effect of combined administration of an lhrh agonist and an antiandrogen on adrenal androgens in patients with cancer of the prostate

✍ Scribed by A. Belanger; A. Dupont; F. Labrie; J.P. Raynaud

Book ID: 116003893
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 98 KB
Volume: 19
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(83)91941-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New hormonal treatment in cancer of the

New hormonal treatment in cancer of the prostate: Combined administration of an LHRH agonist and an antiandrogen

✍ F. Labrie; A. Dupont; A. Belanger; F.A. Lefebvre; L. Cusan; G. Monfette; J.-G. L 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 987 KB

LOSS OF LUTEINIZING HORMONE BIOACTIVITY

LOSS OF LUTEINIZING HORMONE BIOACTIVITY IN PATIENTS WITH PROSTATIC CANCER TREATED WITH AN LHRH AGONIST AND A PURE ANTIANDROGEN

✍ R. ST-ARNAUD; R. LACHANCE; SUSAN J. KELLY; BELANGER. A. DUPONT; F. LABRIE 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

442 Marked loss of LH bioactivity in men

442 Marked loss of LH bioactivity in men with cancer of the prostate treated with an LHRH agonist and an antiandrogen

✍ R. St-Arnaud; S. Kelly; A. Dupont; A. Belanger; F. Labrie 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Pituitary desensitization and loss of lu

Pituitary desensitization and loss of luteinizing hormone bioactivity in men with cancer of the prostate following chronic treatment with an lhrh agonist and an antiandrogen

✍ R. St-Arnaud; R. Lachance; A. Bélanger; A. Dupont; F. Labrie 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 84 KB

142. Long-term (5-month treatment) inhib

142. Long-term (5-month treatment) inhibitory effects of combined administration of an lhrh agonist and a pure antiandrogen on secondary sex organ weight in the male rat

✍ F.A. Lefebvre; A. Bélanger; C. Séguin; J.P. Raynaud; F. Labrie 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Growth-inhibitory effects of luteinizing

Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice

✍ Donatella Dondi; Roberta M. Moretti; Marina Montagnani Marelli; Graziella Prates 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 2 views

Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for